Aromatase in the Human Brain.
Iñigo AzcoitiaPablo MendezLuis-Miguel Garcia-SeguraPublished in: Androgens: clinical research and therapeutics (2021)
The aromatase cytochrome P450 (P450arom) enzyme, or estrogen synthase, which is coded by the CYP19A1 gene, is widely expressed in a subpopulation of excitatory and inhibitory neurons, astrocytes, and other cell types in the human brain. Experimental studies in laboratory animals indicate a prominent role of brain aromatization of androgens to estrogens in regulating different brain functions. However, the consequences of aromatase expression in the human brain remain poorly understood. Here, we summarize the current knowledge about aromatase expression in the human brain, abundant in the thalamus, amygdala, hypothalamus, cortex, and hippocampus and discuss its role in the regulation of sensory integration, body homeostasis, social behavior, cognition, language, and integrative functions. Since brain aromatase is affected by neurodegenerative conditions and may participate in sex-specific manifestations of autism spectrum disorders, major depressive disorder, multiple sclerosis, stroke, and Alzheimer's disease, we discuss future avenues for research and potential clinical and therapeutic implications of the expression of aromatase in the human brain.
Keyphrases
- major depressive disorder
- resting state
- white matter
- poor prognosis
- functional connectivity
- multiple sclerosis
- autism spectrum disorder
- cerebral ischemia
- bipolar disorder
- healthcare
- binding protein
- single cell
- mental health
- stem cells
- gene expression
- long non coding rna
- subarachnoid hemorrhage
- genome wide
- spinal cord injury
- mesenchymal stem cells
- cognitive impairment
- risk assessment
- dna methylation
- bone marrow
- attention deficit hyperactivity disorder
- human health